Shares of marketing firm Chime Communications rallied after it confirmed it has agreed to buy pharmaceutical market access and data firm pH Associates for an initial sum of £6.92m.
The initial consideration comprises £6.07m in cash, and £0.85m in cash representing working capital of PHA at acquisition that is surplus to requirements after PHA joins the group, Chime explained in a company statement.
Further tranches of deferred contingent payment of up to £14m may be payable depending upon the future trading performance of PHA, Chime added.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
PHA, whose clients include Abbott, Janssen Cilag, Novartis and Sanofi, will operate as part of Chime's healthcare division, OPEN Health.
"The acquisition of PHA is a very significant further step in the development of the market access discipline of Chime's healthcare business, OPEN Health," it said.
Chime expects the acquisition of PHA to be immediately earnings enhancing.
CJ
-
Review: Rosi at the BeaumontProper pork pie is just one of many nods to the past at this playful, inviting Mayfair eatery, says Dan McEvoy
-
Lioness legend Jill Scott: “I want to be a role model to get women into investing”Lioness Jill Scott says she wants to be a role model for women to start investing, in the same way she inspired girls to play football. She also questions why topics like investing, tax and mortgages aren’t taught in schools
